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        Infl  uenza type A is a cytolytic virus that causes 
acute respiratory infection, of which the clinical 
outcome can vary greatly. The way in which 
the innate and adaptive immune systems ini-
tially recognize and deal with replicating virus 
could be decisive in determining the outcome 
of infection, as this might heavily influence 
the kinetics of viral clearance (  1  –  3  ). Little is 
known about the initial recognition event of 
infl  uenza virus by the lung immune system 
in vivo  .   
  In immediate response to viral infection, 
innate defense mechanisms consist of high level 
production of type I IFNs by infected epithelial 
cells, alveolar macrophages, and natural IFN-
producing cells (also known as preplasmacytoid 
DCs [pre-pDCs]), as well as the recruitment 
of conventional DCs (cDCs), neutrophils, and 
NK cells (  4, 5  ). By expressing a wide array of 
microbial pattern recognition receptors shared 
with cells of the innate immune response, and 
at the same time displaying the potential to pro-
cess and present antigen to naive T cells, DCs 
bridge innate and adaptive immunity. After rec-
ognizing foreign antigen in the periphery of the 
body, DCs migrate via aff  erent lymphatics into 
the draining LNs, where they can induce anti-
gen-specifi  c protective CD8 CTL responses, as 
well as CD4 T helper cells that enforce cellular 
and humoral immunity (  6  ). 
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  Although dendritic cells (DCs) play an important role in mediating protection against 
infl  uenza virus, the precise role of lung DC subsets, such as CD11b        and CD11b  +   conven-
tional DCs or plasmacytoid DCs (pDCs), in different lung compartments is currently un-
known. Early after intranasal infection, tracheal CD11b       CD11c  hi   DCs migrated to the 
mediastinal lymph nodes (MLNs), acquiring co-stimulatory molecules in the process. This 
emigration from the lung was followed by an accumulation of CD11b  +  CD11c  hi   DCs in the 
trachea and lung interstitium. In the MLNs, the CD11b  +   DCs contained abundant viral 
nucleoprotein (NP), but these cells failed to present antigen to CD4 or CD8 T cells, whereas 
resident CD11b       CD8      +   DCs presented to CD8 cells, and migratory CD11b       CD8            DCs 
presented to CD4 and CD8 T cells. When lung CD11c  hi   DCs and macrophages or 
langerin  +  CD11b       CD11c  hi   DCs were depleted using either CD11c  –  diphtheria toxin receptor 
(DTR) or langerin-DTR mice, the development of virus-specifi  c CD8  +   T cells was severely 
delayed, which correlated with increased clinical severity and a delayed viral clearance. 
120G8  +   CD11c  int   pDCs also accumulated in the lung and LNs carrying viral NP, but in their 
absence, there was no effect on viral clearance or clinical severity. Rather, in pDC-depleted 
mice, there was a reduction in antiviral antibody production after lung clearance of the 
virus. This suggests that multiple DCs are endowed with different tasks in mediating pro-
tection against infl  uenza virus. 1622 DC SUBSETS IN INFLUENZA VIRUS INFECTION   | GeurtsvanKessel et al. 
present antigen to specifi  c CD8 and CD4 T cells. Using genetic 
cell-specifi  c targeting techniques, CD11c  hi   DCs and macro-
phages or langerin  +  CD11c  hi   DCs could be depleted in CD11c  –
  diphtheria toxin receptor (DTR) or langerin-DTR mice ( 36, 37 ), 
and pDCs could be depleted using mAbs. Collectively, our 
results demonstrate that diff  erent DC subsets perform special-
ized tasks during the primary encounter with infl  uenza virus 
in the lung. 
    RESULTS   
  Lung DC subtypes and alveolar macrophages respond 
to infl  uenza virus infection differentially 
  As expected after i.n. inoculation with 5   ×   10  5   tissue culture 
ID  50   infl  uenza A virus X-31 (H3N2), there was induction of 
vigorous innate and adaptive immune responses in the lung. 
The innate cellular immune response was already present 
1 day postinfection (dpi) and peaked at 4 dpi, exemplifi  ed by a 
strong increase in neutrophils. B lymphocytes (CD19  +  ) were 
present in the lung by day 4 and peaked around day 10. Total 
CD8  +   cells in the lung peaked around day 10 (Fig. S1, available 
at http://www.jem.org/cgi/content/full/jem.20071365/DC1). 
To investigate the number of DC subsets and macrophages 
after infl  uenza virus infection, enzymatically digested lungs 
(from which the large conducting airways were dissected) 
were analyzed at diff  erent time points after infection by eight-
color fl  ow cytometry. Digested lung cells were fi  rst gated for 
live leukocytes and expression of the panleukocyte marker 
CD45. cDCs were characterized as low fl  uorescent cells, with 
a CD45  hi  , MHCII  hi   CD11c  hi   phenotype (Fig. S2 A), and further 
subdivided into CD11b  +   or CD11b        cells (  11, 15, 30, 13  ). 
As previously described, pDCs were small, low autofl  uores-
cent cells expressing a CD45  hi  , CD11b  lo  , MHC  int   CD11c  int   
mPDCA-1  +   phenotype (Fig. S2 B) (  24  ). Alveolar macrophages 
were identifi  ed in the bronchoalveolar lavage (BAL) fl  uid as 
highly fl  uorescent cells with a CD11c  hi  , CD11b  lo  , MHCII  lo  , 
F4/80  hi   phenotype (Fig. S2 C). The use of CD11c and CD11b 
expression in combination with the autofl  uorescence typically 
seen in alveolar macrophages adequately discriminated alveolar 
DCs from macrophages, as previously described (  38, 39, 11  ). 
  In the mock situation, 65% of CD11c  hi   DCs were CD11b        
and 35% were CD11b  +  . After infection with infl  uenza virus 
X-31, a signifi  cant increase in both CD11b  +   (  Fig. 1 A  ) and 
CD11b        (  Fig. 1 B  ) lung DCs was seen from 2 dpi, and these 
DC subsets remained increased up to at least 10 dpi.   The DCs 
expressed high levels of MHCII and up-regulated maturation 
markers such as CD86 (  Fig. 1, A and B  ), CD40, CD80, and 
intercellular adhesion molecule 1 (not depicted). The in-
crease in the expression level of these markers peaked shortly 
after inoculation (2 d) and gradually returned back to the lev-
els seen in mock-infected mice (  Fig. 1, A and B  , bar graphs). 
In contrast, the number of pDCs peaked shortly after infec-
tion (2 dpi) and then returned to baseline conditions (  Fig. 1 C  ). 
This increased recruitment of pDCs was accompanied by a 
distinct but very transient up-regulation of maturation mark-
ers (CD86 is shown). Alveolar macrophages were studied in 
the BAL fl  uid accessible by BAL. This compartment contains 
  In the lung, DCs are situated in immediate proximity to 
the respiratory epithelial cells, where they form an elaborate 
network that rapidly reacts to all kinds of foreign antigens and 
infl   ammatory stimuli, including respiratory viruses (  7  –  10  ). 
Diff  erent DC subsets can be found in the lung, each with 
a functional specialization (  11  –  15  ). In the mouse, all DC sub-
sets express the integrin CD11c, and subsets are further de-
fi  ned based on the expression of the marker CD11b, as well 
as anatomical location (  11, 13, 16  ). The trachea and large 
conducting airways have a well-developed network of in-
traepithelial DCs, even in steady-state conditions (  17, 18  ). 
These cells have been shown to express langerin and CD103 
while lacking expression of CD11b (  13, 10, 15  ). In the sub-
mucosa of the conducting airways, CD103       CD11b  +  CD11c  +   
cDCs can be found, particularly under conditions of infl  am-
mation, and these cells might be particularly suited for priming 
and restimulating eff  ector CD4 cells in the lung in response 
to protein antigens (  19, 20, 15  ). The lung interstitium that is 
accessible by enzymatic digestion also contains CD11b  +   and 
CD11b        DCs that access the alveolar lumen and migrate to 
the mediastinal LNs (MLNs) (  14, 11  ). In the nearby alveolar 
lumen, CD11c  hi   alveolar macrophages control the function 
of these interstitial DCs (  21  ). pDCs are CD11b       CD11c  int   cells 
expressing SiglecH and bone marrow stromal antigen 2 (rec-
ognized by the mAbs mouse pDC antigen 1 [mPDCA-1] or 
120G8) (  22, 23  ). In the lungs, pDCs are predominantly found 
in the lung interstitium and produce large amounts of IFN-     
in response to triggering by CpG motifs or viral infection ex 
vivo (  24, 5  ). Under particular conditions, lung pDCs can pre-
vent immunopathology in response to inhalation of harmless 
antigens or in response to respiratory syncitial virus (  24  –  26  ). 
  Several investigators have studied the involvement of APCs 
such as DCs, macrophages, and B cells in mediating protective 
immunity to infl  uenza virus (  27  ). It was previously shown 
that a mouse-adapted strain of infl  uenza virus induced the in 
vivo maturation of CD11c  +   DCs in the lung (  28  ) and their 
migration to the MLNs (  29, 8, 2  ). DCs isolated ex vivo from 
the MLNs of infl  uenza-infected mice presented viral nucleo-
protein (NP)-derived peptides to virus-specifi  c CD8 T cells 
in vitro for at least 10 d, a peak occurring     72 h after infec-
tion (  27, 29  –  32  ). In humans, both monocyte-derived DCs and 
pDCs were shown to be capable of activating already primed 
infl  uenza-specifi  c T cells in vitro (  33, 34  ) and upon adoptive 
transfer in vivo (  35  ). 
  Although these studies certainly suggest the strong in-
volvement of DCs in mediating protective immunity to in-
fl  uenza A virus, direct description of the functional in vivo 
involvement of the now well-described DC subsets in the 
diff  erent compartments of the lung during early infection is 
lacking. In this paper, using eight-color fl  ow cytometry, we 
have carefully studied the kinetics of the reaction of diff  erent 
DC subsets and alveolar macrophages in various lung com-
partments to intranasal (i.n.) infection with infl  uenza virus 
X-31 (H3N2), focusing particularly on CD11b  +   and CD11b        
subsets, as well as on pDCs, describing which subsets carry 
viral NP to the nodes, and carefully dissecting which subsets JEM VOL. 205, July 7, 2008 
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strong decrease in the density of cells staining for MHCII, 
followed by a restoration to baseline density and morphol-
ogy by 10 dpi. To better quantify these changes, eight-color 
fl  ow cytometry was performed on tracheal digestions, dem-
onstrating considerable heterogeneity in DCs at various time 
points after infection (  Fig. 2 B  ). In the mock situation, all 
CD45  +   MHCII  +   cells expressed CD11c, identifying them as 
DCs. The majority of these cells (    75%) were CD11b        and 
expressed the mucosal       E   integrin marker CD103 (  Fig. 2 C  ). 
At 2 dpi, this subset was depleted from the tracheal digest and 
a majority of cells now expressed CD11b but lacked CD103, 
which was most consistent with the phenotype of a freshly 
recruited monocyte-derived DC (  Fig. 2, B and C  ). A tempo-
rary increase in the expression level of CD86 was found on 
these CD11b  +   DCs at day 2 (  Fig. 2 B  ). At 10 dpi, the subset 
balance between CD11b  +   and CD11b        DCs was almost re-
stored to baseline, and cells again showed a highly dendritic 
morphology and CD86 expression returned to baseline levels. 
a large amount of resident alveolar macrophages in mock 
  situation. After infl  uenza virus infection, there was a nonsig-
nifi  cant trend of increase in the alveolar macrophage number 
at 4 dpi (  Fig. 1 D  ), accompanied by a temporary increase in 
CD86 and a more continual increase in MHCII expression 
(mean fl  uorescence intensity [MFI] of 820 in mock and 2,769 
at 10 dpi). 
  Response of DC subsets in the large conducting airways 
to infl  uenza virus infection 
  To examine the DC network in the large conducting airways, 
we stained in vivo fi  xed and permeabilized tracheal whole 
mounts with an mAb to MHCII, revealing the presence of 
a highly developed network of DCs and demonstrating deli-
cate dendritic processes in between bronchial epithelial cells 
(  Fig. 2 A  ).   After infection, there was an increase in MHCII  +   
cells at 2 dpi, and cells had a more rounded appearance, mak-
ing it diffi   cult to quantify DC density. At 4 dpi, there was a 
    Figure 1.         Number and surface phenotype of mouse lung CD11b  +   and CD11b            DCs, pDCs, and alveolar macrophages after infl  uenza 
infection.   Populations were gated as shown in Fig. S2 (available at http://www.jem.org/cgi/content/full/jem.20071365/DC1) and as indicated by the gates 
in the left column of each panel. (A) CD11b  +   DCs signifi  cantly increased after infection and remained increased up to 10 dpi (left). CD86 expression was 
plotted in histograms (right), with MFI shown in the graph (bottom). (B) The increase in CD11b        DCs is demonstrated in fl  ow cytometric plots (left), 
with absolute numbers shown in the graph (bottom). CD86 expression was up-regulated and plotted as MFI (C, bottom). pDCs increased signifi  cantly 
at 2 dpi and then returned to baseline. Recruitment of pDCs was accompanied by up-regulation of CD86 (right). (D) Alveolar macrophages slightly 
increased in number, but CD86 expression was not increased. Gray histograms represent isotype controls and were measured at 4 dpi. The values 
are representative of fi  ve mice per group and are expressed as mean   ±   SEM. Similar results were obtained from at least three separate experiments. 
*, P   <   0.05; **, P   <   0.01.     1624 DC SUBSETS IN INFLUENZA VIRUS INFECTION   | GeurtsvanKessel et al. 
that were further discriminated based on expression of the my-
eloid marker CD11b (  Fig. 3 B  ).   After infection, there was an 
increase in the absolute amount of CD11c  +  MHCII  +  CD11b        
and CD11c  +  MHCII  +  CD11b  +   DCs starting at 2 dpi, and the 
increase was more pronounced in the CD11b  +   subset. Within 
the CD11b       CD11c  hi   cells, there was a clear increase in cells 
coexpressing langerin and CD103 (30   ×   10  4   cells at 4 dpi vs. 
2   ×   10  4   cells in mock-infected mice). Belz et al. previously 
suggested that a resident subset of CD11b       CD8      +   DCs was 
responsible for generating virus-specifi  c CD8 CTLs, whereas 
the population of CD11b       CD11c  +   cells transported antigen from 
the periphery (  30  ). Therefore, cells were further discriminated 
As previously reported (  11  ), we detected a minor percentage 
(0.35% of live tracheal CD45  +   leukocytes) of mPDCA-1  +   
pDCs in tracheal digests of mock-infected mice (  Fig. 2 D  ). 
Again, pDCs increased after infl  uenza virus infection and tem-
porarily up-regulated their expression of co-stimulatory mole-
cules (  Fig. 2 E  ). 
  Infl  uenza virus infection increases DC subsets in MLNs 
  Upon recognition of antigen, lung DCs are known to migrate 
to the MLNs. We followed the kinetics of increase and ex-
pression of maturation markers on various DC subsets within 
this node. cDC subsets were CD11c  +  MHCII  +   cells (  Fig. 3 A  ) 
    Figure 2.         DC subtypes in tracheal tissue after infl  uenza infection.   (A) Tracheal whole mount sections stained for MHCII expression were per-
formed at various days after infection. Bar, 35   μ  m. (B) Flow cytometric analysis of DCs in tracheal cell suspensions stained for CD45, CD11c, CD11b, 
F4/80, and CD103. CD11c  +   cells contained two subsets, one CD11b        and the other CD11b  +  . Histograms represent CD86 expression on both subsets. 
The dotted lines indicate MFI in a mock situation. (C) Absolute numbers of the two subsets after infl  uenza infection expressed as mean values   ±   SEM. 
*, P   <   0.05; **, P   <   0.01. Histograms represent CD103 expression on both subsets. (D) pDCs were identifi  ed as CD11c  int PDCA-1 +   cells representing a 
minor percentage of CD45  +   leukocytes in tracheal cell suspensions and only temporarily expressing CD86 (histogram). (E) Absolute number of pDCs 
at various days after infection expressed as mean values   ±   SEM. **, P   <   0.01.     JEM VOL. 205, July 7, 2008 
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    Figure 3.         DC subsets in MLNs after infl  uenza virus infection.   (A) Kinetics of CD11c  + MHCII +   DCs demonstrating an almost fourfold increase after 
infection. Percentages of living cells are shown. (B) Expression of CD11b by CD11c  +   DCs gated in A. The values are representative of fi  ve mice per group 
and are expressed as mean   ±   SEM. Similar results were obtained from separate experiments. (C) CD8     expression on different DC subsets was demon-
strated in combination with CD11b, with percentages of the different populations plotted in the graph. The values are representative of fi  ve mice per 
group and are expressed as mean   ±   SEM. Similar results were obtained from separate experiments. *, P   <   0.05. (D) CD86 expression on different MLN 
subsets. The gray histogram represents isotype control, the dotted histogram represents mock controls, and the black histogram represents infected 
animals. (E) Sorted DC subsets were stained for intracellular NP. Uninfected cells stain dull red because of Evan  ’  s blue in the solution, and the green 
fl  uorescence indicates NP. Bar, 20   μ  m. These images are representative of one experiment out of at least fi  ve performed. (F) Flow cytometric analysis of 
the total detectable amount of intracellular NP in DC subsets as a percentage of total live LN cells per DC subset. The values are representative of fi  ve 
mice per group and are expressed as mean   ±   SEM. Similar results were obtained from two separate experiments. (G) Plots represent CFSE-labeled T cell 
proliferation 4 d after co-culture with the various sorted DC populations obtained from pooled LNs of 20 infl  uenza-infected mice. (top) CD8  +   T cells and 
(bottom) CD4  +   T cell proliferation are shown. Numbers (top left corners) represent the percentage of cells recruited into cell division. Cell sortings with 
co-culture were performed three times each, and the results shown are representative plots of these experiments.     1626 DC SUBSETS IN INFLUENZA VIRUS INFECTION   | GeurtsvanKessel et al. 
of infection was determined by measuring body weight. 
In general, mice show a maximal 10% weight loss after a mild 
X-31 infection and rapidly regain weight once the virus has 
been cleared from the lungs. When CD11c-DTR Tg mice 
were treated with DT before infection, the clinical sever-
ity of infection dramatically increased and mice lost up to 
20% of their weight, representing a sublethal infection. This 
weight loss could not be attributed to DT treatment, as the 
control group, which was treated with DT before mock in-
fection, did not lose weight (  Fig. 4 B  ). As weight loss might 
be related to the initial severity of infection or failure of the 
immune system to clear infectious particles from the lung, 
we next studied the generation of an effi   cient immune re-
sponse in CD11c  hi    –  depleted mice. For effi   cient lung clear-
ance of a primary infl  uenza virus infection, CD8  +   CTLs play 
an important role. We therefore measured the number of 
NP  366-374   peptide/H-2D  b    –  specifi  c CTL cells using tetramer 
reagents and correlated their numbers to viral clearance. In DT-
treated and -infected animals, the number of virus-specifi  c 
CTLs was signifi  cantly reduced in the lung, spleen (  Fig. 4 C  ), 
and MLN (not depicted). In addition to the measurement of 
CTL, CD3-stimulated IFN-     production by CD4 and CD8 
T cells from MLNs was determined and dramatically sup-
pressed in the absence of DCs (  Fig. 4 D  ). 
  As induction of virus-specifi  c CTL responses is necessary 
for viral clearance from the lung, we measured viral titers 
in the lungs. In this mild infection model, virus is normally 
cleared completely at 8 dpi (  Fig. 4 E  ) (  42  ). However, in the 
absence of lung CD11c  hi   cells and mediastinal CD8     +  CD11c  hi   
cells, the virus had not been cleared at this time. 
  A delay in viral clearance could be caused by a direct de-
fect in CTL priming but could also result from a less effi   cient 
innate response consisting mainly of type I IFN production. 
IFN-     has been described as an important antiviral cytokine 
that is mainly produced by epithelial cells and alveolar macro-
phages, but also by pDCs and even myeloid DCs after in-
fl  uenza infection in vitro (  3, 5  ). We therefore determined 
IFN-     production in the BAL fl  uid at diff  erent time points 
after infection in CD11c  hi    –  depleted mice. In vivo  ,   IFN-     was 
produced in the lungs after X-31 infection, but levels were 
not aff  ected by CD11c  hi   cell depletion (  Fig. 4 F  ). 
  The data in this paragraph show that lung CD11c  hi   cells 
are required for an effi   cient immune response against infl  uenza 
virus infection. However, as CD11c is also highly expressed 
by alveolar macrophages and these cells are also depleted by 
local i.t. administration of DT, we performed adoptive transfer 
reconstitution experiments (  19, 37  ). Tg mice depleted of 
CD11c  hi   cells therefore received i.t. unpulsed wild-type CD11c  hi   
DCs or alveolar macrophages at the moment of infection. 
DCs were capable of restoring the CTL response (  Fig. 4 G  ), 
and as a consequence, viral clearance from the lung was com-
plete by day 8 (  Fig. 4 G  , right). Alveolar macrophages were 
not capable of restoring antiviral immunity or viral clearance. 
These experiments demonstrated that CD11c  hi   DCs are suf-
fi  cient for inducing an adequate immune response against in-
fl  uenza virus infection. 
based on CD8     (  Fig. 3 C  ). Compared with mock-infected 
mice, at 4 dpi there was a generalized increase in all CD8            
subsets (CD11b        and CD11b  +  ), whereas the resident CD8      + 
CD11b        DCs were not increased. After infection, CD11c  + 
MHCII  +   cells had higher levels of the CD86 maturation 
marker compared with mock-infected mice, which was con-
sistent with their potential to prime CD8 T cell responses 
(  Fig. 3 D  ), and this was found in all DC subsets. 
  To test the antigen-presenting potential of the various DC 
subsets in the MLNs, mice were infected with infl  uenza virus 
encoding either the immunodominant OVA  257-264   K  b    –  restricted 
MHCI epitope recognized by the OT-I TCR-transgenic (Tg) 
strain (  40  ) or carrying the OVA  323-339   MHCII epitope recog-
nized by the OT-II TCR-Tg strain (  41  ), allowing us to probe 
presentation of sorted lung DC subsets to naive OVA-specifi  c 
CD8 and CD4 T cells directly ex vivo. To have an indication 
of the uptake of viral antigen or virally infected apoptotic cells, 
preparations of sorted DC subsets from the MLNs were also 
stained for the presence of viral NP using a specifi  c antibody 
(  Fig. 3 E  ), and confi  rmed using eight-color fl  ow cytometric 
staining on permeabilized cells (  Fig. 3 F  ). Viral NP was found, 
particularly in the CD11b  +  CD8            subset as well as abun-
dantly in the pDC subset, and was practically absent from the 
CD11b        subsets (  Fig. 3 F  ). When DC subsets were sorted 
and co-cultured with OVA-specifi  c OTI cells (  Fig. 3 G  , top) 
or OTII cells (  Fig. 3 G  , bottom), the CD11b       CD8            subset 
presented antigen to both CD8 and CD4 T cells, whereas the 
CD11b       CD8      +   resident DCs presented exclusively to CD8 
cells. Despite the fact that these cells had seen viral antigens 
(  Fig. 3, E and F  , NP staining), the CD11b  +   DCs and pDCs 
did not present antigen to naive CD4 or CD8 T cells. As a 
control, OT-I or OT-II T cells incubated with total MLN 
DCs obtained from mice infected with the virus containing 
the OVA-MHCII or   –  MHCI epitope, respectively, failed 
to proliferate. 
  Conditional depletion of lung CD11c  hi   cells aggravates 
features of infection 
  DCs are extremely potent APCs that are uniquely suited to 
prime naive T cells. To study the immune response against 
infl  uenza virus infection with and without CD11c  hi   DCs, 
CD11c-DTR mice were treated with DT intratracheally (i.t.) 
1 d before infection with infl  uenza virus X-31. By this localized 
treatment, lung CD11c  hi   DCs (both CD11b  +   and CD11b       ) 
and alveolar macrophages were effi   ciently depleted from the 
lungs (  Fig. 4 A  ).   In the trachea, the localized treatment with 
DT led to a reduction of CD11b  +   DCs, but not to depletion 
of CD11b        DCs (Fig. S3 A, available at http://www.jem
.org/cgi/content/full/jem.20071365/DC1) or pDCs (not de-
picted). In the MLNs, all DC subsets were partially depleted 
after DT treatment, with the biggest depletion occurring 
in the resident CD11b       CD8      +   DCs (Fig. S3 B) (  19, 37  ). 
On the contrary, CD11c  hi   cells in the spleen or nondraining 
LNs were not aff  ected (unpublished data) (  19, 37  ). At diff  er-
ent time points after infection, the clinical immune response 
and viral replication were analyzed. First, clinical severity JEM VOL. 205, July 7, 2008 
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  Depletion of lung langerin  +   DCs aggravates 
infection parameters 
  The conditional depletion of CD11c  hi   cells in CD11c-DTR 
mice did not allow us to address the contribution of tracheal 
CD11b       CD11c  hi   DCs, as neither tracheal CD11b-CD11c  hi   
DCs nor their CD11b        progeny in the MLNs were depleted 
in CD11c-DTR mice. Therefore, we performed experiments 
in langerin-DTR mice. When DT was administered i.t. to 
    Figure 4.         Infection parameters after conditional depletion of CD11c  hi   cells in a CD11c-DTR Tg mouse model.   CD11c-DTR Tg mice received an i.t. 
injection of DT on day     1, followed by X-31 i.n. infection. (A) Effi  cient depletion of lung CD11c  hi   cells by DT treatment compared with PBS treatment. (right) 
Plots demonstrate fl  ow cytometry data, and numbers indicate the percentage of live cells within each gate. (B) Body weight after infl  uenza infection. A weight 
loss of 20% represents a sublethal infection. (C) Virus-specifi  c CTL response in spleen and lung as measured by Flu  peptide /H-2D b   tetramer (TM) staining. (D) IFN-     
levels in supernatants of MLN cell cultures restimulated with anti-CD3 antibody. (E) Viral titers measured in lung tissue after infl  uenza X-31 infection. Virus is 
normally completely cleared at 8 dpi. nd, nondetectable. (F) IFN-     levels in BAL fl  uid. (G) Adoptive transfer of wild-type DCs and alveolar macrophages into 
DT-treated CD11c-DTR Tg mice before viral infection. CD11c-DTR Tg mice were either treated with PBS or DT, and received either DCs or macrophages before 
infl  uenza infection. Numbers of Flu  peptide /H-2D b  – specifi  c CTLs in spleen suspensions (left) and viral titer in lung tissue (right) are shown. The values are represen-
tative of fi  ve mice per group and are expressed as mean   ±   SEM. Similar results were obtained from at least two separate experiments. *, P   <   0.05; **, P   <   0.01.    1628 DC SUBSETS IN INFLUENZA VIRUS INFECTION   | GeurtsvanKessel et al. 
reduction in the protein level of IFN-     in the BAL fl  uid or 
in the mRNA level for IFN-     in lung tissue after the deple-
tion of pDCs (  Fig. 6 F  ). 
  The production of hemagglutinin (HA)-specifi  c antibodies 
depends on pDCs and not on CD11c  hi   DCs 
  The induction of antiviral CD8 T cell responses is only one 
aspect of adaptive immunity to infl  uenza. We also measured 
the production of serum HA-specifi  c antibodies at 8 and 28 dpi 
by measuring HA inhibition (HI) titers. Although there was 
no eff  ect on the induction of CD8 responses after 120G8-
mediated pDC depletion, virus-specifi  c antibody titers mea-
sured at both time points were signifi  cantly reduced (  Fig. 7 A  ).   
We found no evidence for 120G8 staining on lung B cells, 
making it unlikely that this would be a depleting eff  ect of 
120G8 on B cells directly (unpublished data). Antibody re-
sponses were maintained in mice depleted of CD11c  hi   DCs 
by DT treatment of CD11c-DTR mice 1 d before infection 
in CD11c-DTR mice (  Fig. 7 B  ). 
    DISCUSSION   
  Belz et al. have elegantly described that after infl  uenza in-
fection, both CD11b       CD8      +   resident MLN DCs and the 
CD11b       CD8            lung-derived migratory DC subset pre-
sented antigen to naive CD8  +   T cells ex vivo (  30, 32  ). How-
ever, these authors have not described in detail where exactly 
in the lung these CD11b        migratory DCs originated from 
these mice, there was a strong reduction in CD11b       CD11c  hi   
DCs in the trachea, whereas tracheal CD11b  +   DCs were un-
aff  ected. In the lungs, CD11c  hi   DCs were depleted, whereas 
alveolar macrophages were unaff  ected. The CD8      +  CD11b        
resident MLN cDC subset does not express langerin, and 
consequently, lung administration of DT to these mice only 
led to a reduction in lung-derived CD11b       CD8            migra-
tory DCs (Fig. S3). Depletion of langerin  +   DCs resulted in a 
severe weight loss in the mice until 8 dpi (  Fig. 5 B  ), and this 
was correlated with a signifi  cant decrease in CTL response 
(  Fig. 5 C  ) and a defi  cient viral clearance at 8 dpi (  Fig. 5 D  ).   
  Depletion of pDCs did not alter the course of infection 
  The experiments using CD11c-DTR and langerin-DTR 
mice mainly depleted CD11c  hi   cells, whereas CD11c  int   
pDCs are globally not aff  ected by this targeting strategy (  43  ). 
To additionally address the role of pDCs, we performed ex-
periments in which pDCs were depleted by injection of the 
120G8 mAb (  22  ). Using this antibody, an eff  ective deple-
tion of pDCs to   <  10% of baseline numbers was achieved 
in the lung (  Fig. 6 A  ), as measured using antibodies directed 
against both bone marrow stromal antigen and SiglecH (  24  ).   
Surprisingly, this effi   cient depletion of pDCs did not aff  ect 
any of the infection parameters and virus was cleared effi   ciently 
by 8 dpi (  Fig. 6, B  –  E  ). As pDCs have been previously de-
scribed as the main IFN-      –  producing cells in response to a 
viral infection (  44  ), it was similarly striking that there was no 
    Figure 5.         Effect of conditional depletion of langerin  +   DCs cells during infl  uenza infection.   Langerin-DTR Tg mice received an i.t. injection of DT 
on day     1, followed by X-31 i.n. infection. (A) Effi  cient depletion of MHCII  +  CD11c DCs in lung after DT treatment. Numbers indicate percentages of live 
cells within the gate. (B) Body weight after infl  uenza infection. A weight loss of   >  20% represents a sublethal infection. (C) Virus-specifi  c CTL response in 
spleen and lung measured by Flu  peptide /H-2D b   tetramer (TM) staining. (D) Viral titers measured in lung tissue after infl  uenza X-31 infection. Virus is nor-
mally cleared completely at 8 dpi. The values are representative of fi  ve mice per group and are expressed as mean   ±   SEM. Similar results were obtained 
from at least two separate experiments. *, P   <   0.05; **, P   <   0.01. nd, nondetectable.     JEM VOL. 205, July 7, 2008 
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and into the lung interstitium. These cells most likely diff  er-
entiate from recruited Ly6C  +   monocytes that give rise to 
infl  ammatory-type DCs (  16, 45  ), or that arose from local 
proliferation and diff  erentiation of a myeloid precursor popula-
tion that also generates alveolar macrophages (  46  ). An identi-
cal subset of CD11b  +  CD11c  +   DCs was found to be increased 
in the MLNs from days 2 to 4 onwards, again suggesting 
migration from the lungs to the MLN. 
  It was striking that there were several subsets of DCs 
found to be recruited and/or activated in the MLNs after in-
fl  uenza infection, strongly suggesting the division of labor 
between various APCs. Recently, several papers have shown that 
the cross presentation of exogenous harmless or viral antigen 
to CD8  +   lymphocytes or presentation of exogenous antigen 
to CD4 T cells is a mutually exclusive function of CD8      +   or 
and whether any of the DCs would also present to CD4  +   T 
cells, and they have also not studied in detail the precise con-
tribution of infl  ammatory CD11b  +   DCs or pDCs that are re-
cruited to infl  amed lungs. 
  Our studies on the various anatomical lung compartments 
suggest that a predominant source of CD11b        DCs arriving 
in the MLNs are from the network of highly dendritic-shaped 
CD103  +   intraepithelial DCs that lines the large conducting 
airways (  Fig. 1  ) (  18, 13  ). There was a marked decrease in this 
subset of highly dendriform tracheal CD11b       CD103  +   DCs 
at 2 dpi, at a time that the langerin  +  CD103  +  CD11b       CD8            
DCs started to accumulate in the MLNs. The disappearance 
of CD11b       CD11c  +   tracheal DCs was accompanied by a new 
infl  ux of CD11b  +  CD11c  +   DCs into the trachea (present as 
more rounded cells at day 2 after infection on whole mounts) 
    Figure 6.         Infection parameters after infl  uenza in mice depleted of pDCs.   Mice received three i.p. injections of the depleting mAb 120G8 before 
infection with infl  uenza on day 0. (A) Effi  cient depletion of lung pDCs after 3 d of 120G8 i.p. treatment compared with PBS treatment. (B) Body weight 
after infection. (C) Virus-specifi  c CTL responses in spleen and lung cell suspensions, as measured by Flu  peptide /H-2D b   tetramer staining. (D) IFN-     levels  in 
supernatants of MLN cell cultures restimulated with anti-CD3 antibody. (E) Viral titers in lung after infl  uenza infection. (F) IFN-     levels in BAL fl  uid. The 
values are representative of fi  ve mice per group and are expressed as mean   ±   SEM. Similar results were obtained from at least two separate experiments. 
*, P   <   0.05; **, P   <   0.01.     1630 DC SUBSETS IN INFLUENZA VIRUS INFECTION   | GeurtsvanKessel et al. 
Our data on viral NP staining suggest that the CD11b  +   DCs 
as well as the pDCs were abundantly positive for viral antigen 
in the MLNs and, therefore, could be the most important 
source for providing viral antigens to resident CD8      +   DCs. 
  Another striking observation was the fact that the CD11b  + 
CD11c  +   subset found to be increased in the trachea, lung, and 
MLNs after infl  uenza infection hardly presented any viral 
antigen to CD4 or CD8 T cells. Clearly, the CD11b  +   DCs had 
seen viral antigens (either directly or through phagocytosis 
of virally infected apoptotic epithelial cells) as they carried an 
abundant amount of viral NP in their cytoplasm. The absence 
of APC function by this subset is in striking contrast to the 
situation when harmless noninfl  ammatory antigen is inhaled 
(  15  ). What could be the purpose of recruitment of a diff  erent 
DC subset, in addition to CD11b        DCs, if these cells do 
not present antigen to naive T cells? First, as these cells have 
been shown to massively produce infl  ammatory chemokines, 
CD11b  +   DCs might be crucial in attracting eff  ector CD4 and 
CD8 cells that have been generated in the LNs back to the 
lung and trachea, where they would mediate eff  ector function 
(  51  ). Second, CD11b  +   DCs might have direct innate antiviral 
activity by producing TNF-     and inducible NO synthase  –
  dependent NO, analogous to the situation seen with   Listera 
monocytogenes   infection (  52, 53  ). Third, recruited CD11b  +   
DCs might also stimulate the innate antiviral activity of NK 
cells. The important function of infl  ammatory DCs in initiat-
ing the innate response is supported by the fact that infl  uenza 
produces the nonstructural protein 1, with a specifi  c aim to 
subvert the innate immune function of the CD11b  +   DC subset 
(  54, 3  ). Future studies in our laboratory will have to address 
the direct or indirect innate and adaptive functions of infl  am-
matory CD11b  +   DCs in infl  uenza infection. 
  Another way to study the function of lung DC subsets is 
to deplete them using various cell-specifi  c genetic targeting 
strategies using expression of the DTR under control of a 
specifi  c promoter and administration of the DT via the air-
ways (  19  ). In CD11c-DTR mice, there is a predominant de-
pletion of lung CD11c  hi   DCs, of tracheal CD11b  +  CD11c  hi   
DCs, and of resident MLN CD8      +  CD11c  hi   DCs. Because 
CD11b       CD11c  hi   migratory tracheal DCs are not depleted in 
these mice, we consequently observed no decrease in MLN 
CD11b       CD8            DCs. In CD11c-DTR mice given DT, we 
noticed that generation of virus-specifi  c CD8  +   CTLs and 
production of eff  ector cytokines (IFN-    ) by MLN cells was 
severely diminished. Based on our antigen presentation stud-
ies and the previous work of Belz et al. (  30  ), we propose that 
this is caused by depletion of the resident CD8      +  CD11c  hi   
DCs or to the depletion of chemokine-producing lung CD11b  +   
DCs. CD11c  hi   alveolar macrophages are also depleted in 
CD11c-DTR mice, although it is unlikely that this contrib-
uted to a decrease in antiviral immunity, as adoptive transfer 
of wild-type DCs but not macrophages restored immunity. 
  To address the specifi  c role of migratory tracheal CD11b        
DCs, we performed experiments in langerin-DTR mice (  36  ). 
Langerin was found to be particularly present on mucosal 
CD11b       CD103  +   DCs in the lung (  13  ), a population of cells 
CD8            DC subsets, respectively (  47  –  49  ). We therefore per-
formed a head-to-head comparison of the potential to present 
viral antigen to naive CD4 or CD8 T cells, taking advantage of 
infl  uenza virus encoding either the MHCI or MHCII immuno-
dominant OVA epitope. 
  As previously described by Belz et al., CD8      +  CD11b        
resident DCs presented viral antigen to naive CD8 cells, sup-
ported by the fact that these cells had up-regulated co-stimu-
latory molecules. Strikingly, the population of airway-derived 
CD11b       CD8            DCs also up-regulated co-stimulatory mol-
ecules and presented not only to CD8 T cells but also to CD4 
T cells. This suggests that processing for and presentation on 
both MHCI and MHCII molecules can occur in a single cell 
population in vivo in the lung, contrary to what was shown 
for the spleen or lymph nodes (  30  ). Vermaelen et al. also pre-
viously demonstrated that antigen presentation of harmless 
antigen to naive CD4 T cells in the MLNs was an exclusive 
function of a migratory DC population (  50  ). Despite the fact 
that both CD8      +   and CD8            CD11b        DCs presented anti-
gen to naive T cells, the strength of viral NP staining was not 
abundant. This could be explained by the fact that viral NP 
was digested in these subsets as part of an antigen-processing 
step, leading to a loss of immunoreactivity toward the NP-
specifi  c antibody. Alternatively, Belz et al. previously sug-
gested that resident CD8      +   cells acquired the antigen from 
other migratory APCs, proposed as the CD11b       CD8            lung-
derived DCs, but this was never directly demonstrated (  30  ). 
    Figure 7.         Virus-specifi  c serum antibodies of infl  uenza virus  –  infected 
mice after DC subset depletion.   (A)  Virus-specifi  c antibodies in the 
serum of C57BL/6 mice after i.p. treatment with 120G8 depleting anti-
body or PBS, or (B) in the serum of CD11c-DTR mice after i.t. treatment 
with DT or PBS, measured at 8 dpi and 1 mo after infection. The values 
are representative of at least fi  ve mice per group and are expressed as 
geometric mean titer (GMT) of HI   ±   SEM. The differences in HI titer can 
be explained by the background of the mice. CD11c-DTR mice were 
F1 (BALB/c   ×   C57BL/6) animals and developed less high viral and HI titers 
than the pure C57BL/6 mice that were used in 120G8 depletion experiments. 
Similar results were obtained from at least two separate experiments. 
*, P   <   0.05; **, P   <   0.01.     JEM VOL. 205, July 7, 2008 
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  MATERIALS AND METHODS 
  Mice.     6  –  8-wk-old C57BL/6 mice were purchased from Harlan. The 
generation and screening of CD11c-DTR Tg mice has been previously 
described (  37  ). Male BALB/c background CD11c-DTR Tg (H2-D  d  ) 
mice were crossed to C57BL/6 (H2-D  b  ), to obtain F1 progeny, to allow 
detection of the H2-D  b   tetramer. CD11c  hi   cells were depleted in CD11c-
DTR   ×   C57BL/6 Tg mice by i.t. injection of 50 ng DT, a dose previ-
ously determined by titration (  15  ). pDCs were depleted by i.p. injection 
of pDC-selective depleting 120G8 antibody (  22  ). All experiments were ap-
proved by an independent animal ethics committee of Erasmus Medical 
Centre Rotterdam. 
  Infl   uenza virus infection.     Infl   uenza virus X-31 (Medical Research 
Council) was inoculated in the allantoic cavity of 11-d-old embryonated 
chicken eggs. The allantoic fl  uid was harvested after 2 d. Infectious vi-
rus titers were determined in Madin-Darby canine kidney (MDCK) cells 
(NBL-2; American Type Culture Collection), as described previously (  60  ). 
Virus titers were obtained at days 4 and 8 after infection. Lungs were stored 
at     70  °  C. Lungs were homogenized with a homogenizer (Polytron; Kine-
matica AG) in infection medium (Eagle  ’  s minimal essential medium), 0.3% 
BSA (fraction V), 4   μ  g/ml trypsin, 2 mM   l  -glutamine, 100 U/ml penicillin, 
100   μ  g/ml streptomycin, 0.15% NaHCO  3  , 20 mM Hepes, and 0.1 mM 
of nonessential amino acids. 10-fold serial dilutions of these samples were 
used 8-fold to determine the virus titers in MDCK cells, as described 
previously (  60  ). For antigen presentation assays of LN DCs, mice were in-
fected with WSN infl  uenza virus encoding the OVA  257-264   K  b    –  restricted 
MHCI epitope in neuraminidase (  40  ), and with X-31 infl  uenza virus en-
coding the OVA  323-339   MHCII epitope in HA of the virus (  41  ). The OVA 
viruses were provided by R. Webby (St. Jude Children  ’  s Research Hospital, 
Memphis, TN). 
  Flow cytometry.     For detection and phenotyping of DCs at days 2, 4, and 
10 after infection, single-cell suspensions of MLNs and lung samples were 
prepared as described previously (  24  ). Trachea was digested in collagenase 
solution for 1 h at 37  °  C to promote the release of DCs. Cells were subse-
quently stained with mAbs directed against MHCII FITC, intracellular NP 
FITC, CD86 PE, CD11c PE Texas red, CD45 PECy5, CD103 PECy7, in-
tracellular langerin APC, mPDCA-1 APC, F4/80 APC Cy7, CD11b Pacifi  c 
blue, and a fi  xable live/dead marker in Aqua (Invitrogen). Acquisition of eight 
to nine color samples was performed on a cytometer (FACSAria) equipped 
with FACSDiva software (both from BD Biosciences). The fi  nal analysis and 
graphical output were performed using FlowJo software (Tree Star, Inc.). 
Cell sorting of DC subsets from MLNs was performed on a FACSAria. 
The purity of sorted populations was   >  95%. 
  Immunofl   uorescence on sorted DC subsets.     Sorted cell populations 
were spotted on microscope slides, dried, and fi  xed in acetone. Subsequently, 
the slides were incubated with FITC-labeled infl  uenza A NP-specifi  c anti-
body (IMAGEN infl  uenza virus; Dako) at 37  °  C for 15 min. The slides were 
washed twice with PBS and once with distilled water, dried, and embedded 
into a glycerol  –  PBS solution (Citifl  uor; UKC Chemlab). Uninfected cells 
stain dull red because of the Evan  ’  s blue in the solution. Green and yellow 
signals indicate the presence of NP. Fluorescence was scored using a fl  uores-
cence microscope (LSM 510; Carl Zeiss, Inc.). 
  Analysis of T cell proliferation.     OT-1 and OT-2 Tg T cells were iso-
lated from spleens and LNs of respective mice, enriched by MACS cell sort-
ing with anti-CD8 or -CD4 antibodies according to manufacturer  ’  s protocol 
(Miltenyi Biotec), and labeled with CFSE (  61  ). Sorted DC subsets were co-
cultured with T cells in a v-bottom plate at a 1:10 ratio for 4 d. T cell divi-
sions were measured by fl  ow cytometry. The percentage of cells recruited 
into each cell division was calculated by dividing the number of individual 
cells by CFSE content, as previously described (  61  ), using the formula 100   ×   
  {  1      [  n    0  /(  n    0   +   n    1  /2 +   n    2  /4 +   n    3  /8 +   n    4  /16 +   n    5  /32 +   n    6  /64 +   n    7  /128)]  }   to 
correct for the multiplying eff  ect of division. 
that strictly relies on CCR7 to migrate to the MLNs (  15  ). 
In accordance, we also found increased numbers of langerin  + 
CD103  +  CD11b       CD11c  +   DCs in the MLNs after infl  uenza 
infection. After i.t. administration of DT, there was a selec-
tive depletion of CD11b       CD8            migratory DCs in the tra-
chea and MLNs, while the CD8      +   resident LN population 
or alveolar macrophages were unaff  ected. In the absence of 
the migratory langerin  +   CD11b        DC population, infl  uenza ran 
a particularly severe course. Strikingly, these data also suggest 
that the langerin  +   DCs of the lung are much more immuno-
genic than their langerin  +   Langerhans cell counterparts in the 
skin (  55, 36, 56  ). 
  Finally, we also addressed the in vivo function of lung pDCs, 
previously known as natural IFN-      –  producing cells (  44  ). In 
humans, these cells produce copious amounts of IFN-     when 
exposed to infl  uenza virus in vitro (  57  ) and have been shown 
to stimulate already-primed infl  uenza-specifi  c CD4 and CD8 
T cells (  34  ). It has therefore been suggested that upon proper 
stimulation, pDCs develop into bona fi  de APCs that primar-
ily stimulate antiviral immune response (  58  ). To address the 
antigen-presenting function of pDCs, we sorted pDCs from 
the MLNs of infected mice and found no evidence for presen-
tation to either CD4 or CD8 T cells ex vivo, despite the fact 
that the cells contained copious amounts of intracellular viral 
NP. Previous studies with other respiratory viruses have sug-
gested that pDCs have a more immunoregulatory role, which is 
crucial for preventing excessive immune activation and immuno-
pathology (  12, 24, 25  ). Although pDCs were attracted to the 
lungs and tracheal wall during infl  uenza infection, their con-
fi  rmed depletion using 120G8 antibody did not aff  ect viral 
titers, generation of virus-specifi  c T cells, or the severity of in-
fection, arguing against a predominant role for pDCs as APCs, 
immunoregulatory cells, or innate immune cells in this mild 
infection model. It was similarly striking to see that there was 
no eff  ect on IFN-     production when pDCs were eff  ectively 
depleted. Infections in epithelial surfaces that bathe in IFN-     
(produced by epithelial cells) might be less dependent on 
IFN-     production by pDCs. Kumagai et al. recently demon-
strated that during lung infection with RNA viruses, alveolar 
macro  phages are a predominant source of type I IFN, and 
that pDCs only start producing IFN-     when macrophages are 
depleted from the lungs (  5  ). The only eff  ect of treatment with 
the 120G8 antibody was a signifi  cant reduction of the titer 
of virus-specifi  c HI antibodies at 8 and 28 dpi, signifying a 
possible role for pDCs in stimulating humoral antiviral im-
munity, as previously suggested (  59  ). Although we found no 
evidence for 120G8 staining on lung B cells after infl  uenza 
infection, treatment with 120G8 antibody could also deplete 
plasma cells directly and in this way reduce HI antibody titers. 
Therefore, we are awaiting more specifi  c (e.g., genetic) pDC 
targeting strategies to address this point further. In conclusion, 
our paper demonstrates a division of labor between diff  erent 
DC subsets during pulmonary infl  uenza infection, knowledge 
that might be used for the design of better infl  uenza vaccines 
and could increase our understanding of why particular strains 
of infl  uenza are more pathogenic than others. 1632 DC SUBSETS IN INFLUENZA VIRUS INFECTION   | GeurtsvanKessel et al. 
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